Botanical source
Dihydromyricetin occurs in Ampelopsis grossedentata, commonly called vine tea, and in Hovenia dulcis, the Japanese raisin tree. Source identity and standardization matter when comparing ingredients.
Joyrise
Loading the current catalog.
Dihydromyricetin
A clear guide to the molecule, the research, and the limits of what anyone should claim.
DHM is a plant flavonoid found in vine tea. Researchers have studied it in alcohol-related, antioxidant, metabolic, and neural-signaling models. Much of the evidence is preclinical, so a mechanism in a cell or animal is not the same as a proven finished-product result in people.
The molecule
Dihydromyricetin occurs in Ampelopsis grossedentata, commonly called vine tea, and in Hovenia dulcis, the Japanese raisin tree. Source identity and standardization matter when comparing ingredients.
DHM is a flavonoid. The name on a label does not tell you its source, purity, formulation, or how much reaches circulation.
Cell, rodent, and limited human evidence should be labeled separately. They do not carry the same certainty.
Pathways are not promises. Each finding needs its model, dose, route, and endpoint attached.
Preclinical studies examine enzymes involved in the conversion of ethanol to acetaldehyde and then acetate. Findings are not a shortcut around time.
The widely cited 2012 UCLA paper used rodent and cell models. It did not test a finished Joyrise product in a human clinical trial.
Researchers have examined antioxidant-response and autophagy pathways, mostly in preclinical settings. Human outcome evidence remains limited.

Why formulation matters
Raw DHM has known solubility and absorption challenges in preclinical research. Joyrise uses a patented delivery approach designed around bioavailability. The patent protects an invention. It does not guarantee that every person will experience the same result.
Primary sources
DHM, or dihydromyricetin, is a naturally occurring flavonoid found in plants including vine tea and Japanese raisin tree.
Researchers have studied DHM in alcohol-related pathways, GABA-A signaling, oxidative-stress responses, and metabolic models. Much of the alcohol-related evidence is from cells and animals.
No. DHM does not lower BAC or impairment, does not make drinking safer, and must never be used as a reason to drive after drinking.
No. Source, dose, delivery system, other ingredients, format, testing, and directions can differ. Compare the current labels, not only the front-of-pack milligram number.
Ready to compare formats?
Joyrise does not reduce impairment or BAC and does not make drinking safer. Never drink and drive.